264 related articles for article (PubMed ID: 20929257)
1. Quo vadis, virtual screening? A comprehensive survey of prospective applications.
Ripphausen P; Nisius B; Peltason L; Bajorath J
J Med Chem; 2010 Dec; 53(24):8461-7. PubMed ID: 20929257
[No Abstract] [Full Text] [Related]
2. Understanding and predicting druggability. A high-throughput method for detection of drug binding sites.
Schmidtke P; Barril X
J Med Chem; 2010 Aug; 53(15):5858-67. PubMed ID: 20684613
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
Yang SY
Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
[TBL] [Abstract][Full Text] [Related]
4. Scaffold hopping using two-dimensional fingerprints: true potential, black magic, or a hopeless endeavor? Guidelines for virtual screening.
Vogt M; Stumpfe D; Geppert H; Bajorath J
J Med Chem; 2010 Aug; 53(15):5707-15. PubMed ID: 20684607
[TBL] [Abstract][Full Text] [Related]
5. Statistical tools for virtual screening.
Krumrine JR; Maynard AT; Lerman CL
J Med Chem; 2005 Nov; 48(23):7477-81. PubMed ID: 16279807
[TBL] [Abstract][Full Text] [Related]
6. Virtual high-throughput screening of molecular databases.
Seifert MH; Kraus J; Kramer B
Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
[TBL] [Abstract][Full Text] [Related]
7. Druggability indices for protein targets derived from NMR-based screening data.
Hajduk PJ; Huth JR; Fesik SW
J Med Chem; 2005 Apr; 48(7):2518-25. PubMed ID: 15801841
[TBL] [Abstract][Full Text] [Related]
8. PHASE: a novel approach to pharmacophore modeling and 3D database searching.
Dixon SL; Smondyrev AM; Rao SN
Chem Biol Drug Des; 2006 May; 67(5):370-2. PubMed ID: 16784462
[No Abstract] [Full Text] [Related]
9. What do medicinal chemists actually make? A 50-year retrospective.
Walters WP; Green J; Weiss JR; Murcko MA
J Med Chem; 2011 Oct; 54(19):6405-16. PubMed ID: 21755928
[No Abstract] [Full Text] [Related]
10. An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs.
Perola E
J Med Chem; 2010 Apr; 53(7):2986-97. PubMed ID: 20235539
[TBL] [Abstract][Full Text] [Related]
11. A unified, probabilistic framework for structure- and ligand-based virtual screening.
Swann SL; Brown SP; Muchmore SW; Patel H; Merta P; Locklear J; Hajduk PJ
J Med Chem; 2011 Mar; 54(5):1223-32. PubMed ID: 21309579
[TBL] [Abstract][Full Text] [Related]
12. Capturing structure-activity relationships from chemogenomic spaces.
Wendt B; Uhrig U; Bös F
J Chem Inf Model; 2011 Apr; 51(4):843-51. PubMed ID: 21410249
[TBL] [Abstract][Full Text] [Related]
13. Novel inhibitors of dengue virus methyltransferase: discovery by in vitro-driven virtual screening on a desktop computer grid.
Podvinec M; Lim SP; Schmidt T; Scarsi M; Wen D; Sonntag LS; Sanschagrin P; Shenkin PS; Schwede T
J Med Chem; 2010 Feb; 53(4):1483-95. PubMed ID: 20108931
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the effectiveness of similarity-based virtual screening using nearest-neighbor information.
Hert J; Willett P; Wilton DJ; Acklin P; Azzaoui K; Jacoby E; Schuffenhauer A
J Med Chem; 2005 Nov; 48(22):7049-54. PubMed ID: 16250664
[TBL] [Abstract][Full Text] [Related]
15. Chemoinformatics-applications in food chemistry.
Martinez-Mayorga K; Medina-Franco JL
Adv Food Nutr Res; 2009; 58():33-56. PubMed ID: 19878857
[TBL] [Abstract][Full Text] [Related]
16. Insights into ligand-elicited activation of human constitutive androstane receptor based on novel agonists and three-dimensional quantitative structure-activity relationship.
Jyrkkärinne J; Windshügel B; Rönkkö T; Tervo AJ; Küblbeck J; Lahtela-Kakkonen M; Sippl W; Poso A; Honkakoski P
J Med Chem; 2008 Nov; 51(22):7181-92. PubMed ID: 18983136
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the relationship between topology and selectivity for druglike molecules.
Yang Y; Chen H; Nilsson I; Muresan S; Engkvist O
J Med Chem; 2010 Nov; 53(21):7709-14. PubMed ID: 20942392
[TBL] [Abstract][Full Text] [Related]
18. Novel approach for chemotype hopping based on annotated databases of chemically feasible fragments and a prospective case study: new melanin concentrating hormone antagonists.
Oyarzabal J; Howe T; Alcazar J; Andrés JI; Alvarez RM; Dautzenberg F; Iturrino L; Martínez S; Van der Linden I
J Med Chem; 2009 Apr; 52(7):2076-89. PubMed ID: 19290642
[TBL] [Abstract][Full Text] [Related]
19. Scaffold distributions in bioactive molecules, clinical trials compounds, and drugs.
Hu Y; Bajorath J
ChemMedChem; 2010 Feb; 5(2):187-90. PubMed ID: 20014088
[No Abstract] [Full Text] [Related]
20. Computational methodologies for compound database searching that utilize experimental protein-ligand interaction information.
Tan L; Batista J; Bajorath J
Chem Biol Drug Des; 2010 Sep; 76(3):191-200. PubMed ID: 20636330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
